Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucidin Cream in the Treatment of Impetigo
2004-002687-14Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of fusidic acid in impetigo, sponsored by LEO Pharma. Primary endpoint: Clinical and bacteriological success at end of treatment. Started Feb 2005; status: completed.
02
Drugs
fusidic acid
03
Conditions
impetigo
Beyond the preview
Go deeper on 2004-002687-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002687-14.